Search research articles
Contact Us
Filters
Showing results (201-210 of 627) with videos related to
Page
of 63
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
The integration of chemotherapy and surgery for bladder cancer
Matthew D Galsky, Harry W Herr, Dean E Bajorin
Genes & Development
|
January 1, 1993
Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment
M A Cleary, S Stern, M Tanaka, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
September 1, 1996
Developmental exposure to Aroclor 1254 produces low-frequency alterations in adult rat brainstem auditory evoked responses
D W Herr, E S Goldey, K M Crofton
The Journal of Urology
|
April 1, 1983
Bladder carcinosarcoma: histologic variation in metastatic lesions
J A Smith, H W Herr, R G Middleton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance
F Rabbani, M Perrotti, P Russo, et al.
Genes & Development
|
November 15, 1994
Multiple regions of TBP participate in the response to transcriptional activators in vivo
W P Tansey, S Ruppert, R Tjian, et al.
The Journal of Urology
|
November 1, 1993
Association of primary germ cell tumor of the testis and renal cell carcinoma
B E Davis, P C Sogani, H W Herr
Urology
|
December 1, 1986
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer
H W Herr, R P Warrel, J H Burchenal
Toxicology and Applied Pharmacology
|
October 1, 1989
Blockade of only spinal alpha 1 adrenoceptors is insufficient to attenuate DDT-induced alterations in motor function
D W Herr, R B Mailman, H A Tilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome
H W Herr, D F Bajorin, H I Scher
Page
of 63
Search research articles
Search
Showing results (201-210 of 627) with videos related to
Sort By:
Page
of 63
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 10, 2009
The integration of chemotherapy and surgery for bladder cancer
Matthew D Galsky, Harry W Herr, Dean E Bajorin
Genes & Development
|
January 1, 1993
Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment
M A Cleary, S Stern, M Tanaka, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
September 1, 1996
Developmental exposure to Aroclor 1254 produces low-frequency alterations in adult rat brainstem auditory evoked responses
D W Herr, E S Goldey, K M Crofton
The Journal of Urology
|
April 1, 1983
Bladder carcinosarcoma: histologic variation in metastatic lesions
J A Smith, H W Herr, R G Middleton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2001
Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance
F Rabbani, M Perrotti, P Russo, et al.
Genes & Development
|
November 15, 1994
Multiple regions of TBP participate in the response to transcriptional activators in vivo
W P Tansey, S Ruppert, R Tjian, et al.
The Journal of Urology
|
November 1, 1993
Association of primary germ cell tumor of the testis and renal cell carcinoma
B E Davis, P C Sogani, H W Herr
Urology
|
December 1, 1986
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer
H W Herr, R P Warrel, J H Burchenal
Toxicology and Applied Pharmacology
|
October 1, 1989
Blockade of only spinal alpha 1 adrenoceptors is insufficient to attenuate DDT-induced alterations in motor function
D W Herr, R B Mailman, H A Tilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 1998
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome
H W Herr, D F Bajorin, H I Scher
Page
of 63